Combination SPCs: shaken and stirred
Following a CJEU decision in July, and with two more cases on the horizon, Joel Beevers and Michael Pears of Potter Clarkson report on whether an active ingredient (or combination of active ingredients) is ‘protected by a basic patent’, as required for a supplementary protection certificate.
LSIPR 50 2018: Elaine Waller
Elaine Waller was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the legal section, as LSIPR reports.
LSIPR 50 2018: Lorie Ann Morgan
Lorie Ann Morgan was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the legal section, as LSIPR reports.
LSIPR 50 2018: Emma Walmsley
Emma Walmsley was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Antoine Petit
Antoine Petit was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
Hatch-Waxman amendment: a Hobson’s choice
If enacted by Congress, the proposed amendment to the Hatch-Waxman Act would spell trouble for generic pharmaceutical companies seeking to take on brand competitors in patent litigation, says Janine Carlan of Arent Fox.
LSIPR 50 2018: Richard Gonzalez
Richard Gonzalez was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
LSIPR 50 2018: Tony Coles
Tony Coles was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
Event preview: BioPharm America 2018
BioPharm America, to be held in Boston on September 5 and 6, 2018, will bring together startups, established companies and investors from the life sciences industry, as Kari Luu reports.
LSIPR 50 2018: Kim Nasmyth
Kim Nasmyth was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the business and innovation section, as LSIPR reports.
